4.2 Article

Interim analysis of the phase 3 CHERISH study evaluating nusinersen in patients with later-onset spinal muscular atrophy (SMA): Primary and descriptive secondary endpoints

Journal

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
Volume 21, Issue -, Pages e15

Publisher

Elsevier BV
DOI: 10.1016/j.ejpn.2017.04.1220

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available